Development and implementation of the quality control panel of RT-PCR and real-time RT-PCR for avian influenza A (H5N1) surveillance network in mainland China

BMC Infectious Diseases

Yuelong Shu²  Wei Wang²  Xiyan Li²  Lei Yang²  Changgui Li¹  Shumei Zou²  Ming Shao¹  Leying Wen²  Yan Gao²  Rongbao Gao² 

[1]The 3rd Division of Viral Vaccine, the National Institute for the Control of Pharmaceutical and Biological Products, Beijing, 100050, PR China

[2]Dept. of Influenza, Chinese National Influenza Center, State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese center for disease control and prevention (China CDC), Beijing 100052, PR China

Others  :  1175782
DOI  :  10.1186/1471-2334-11-67

 received in 2010-10-15, accepted in 2011-03-16,  发布年份 2011

【 摘 要 】

Background

Reverse transcription PCR (RT-PCR) and real time RT-PCR (rRT-PCR) have been indispensable methods for influenza surveillance, especially for determination of avian influenza. The movement of testing beyond reference lab introduced the need of quality control, including the implementation of an evaluation system for validating personal training and sample proficiency testing.

Methods

We developed a panel with lysates of seasonal influenza virus (H1N1, H3N2 and B), serials of diluted H5N1 virus lysates, and in-vitro transcribed H5 hemaglutinin (HA) and an artificial gene RNAs for RT-PCR and rRT-PCR quality control assessment. The validations of stability and reproducibility were performed on the panel. Additionally, the panel was implemented to assess the detection capability of Chinese human avian influenza networks.

Results

The panel has relatively high stability and good reproducibility demonstrated by kappa's tests. In the implementation of panel on Chinese human avian influenza networks, the results suggested that there were a relatively low number of discrepancies for both concise and reproducibility in Chinese avian influenza virus net works.

Conclusions

A quality control panel of RT-PCR and real-time RT-PCR for avian influenza A (H5N1) surveillance network was developed. An availably statistical data, which are used to assess the detection capability of networks on avian influenza virus (H5N1), can be obtained relatively easily through implementation of the panel on networks.

【 授权许可】

   
2011 Gao et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Curran MD, Ellis JS, Wreghitt TG, Zambon MC: Establishment of a UK National Influenza H5 Laboratory Network. J Med Microbiol 2007, 56(Pt 10):1263-7.
• [2]Kimball AM, Moore M, French HM, Arima Y, Ungchusak K, Wibulpolprasert S, Taylor T, Touch S, Leventhal A: Regional infectious disease surveillance networks and their potential to facilitate the implementation of the international health regulation. Med Clin North Am 2008, 92(6):1459-71. xii
• [3]Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY: Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5: Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353(13):1374-85.
• [4]Yu H, Gao Z, Feng Z, Shu Y, Xiang N, Zhou L, Huai Y, Feng L, Peng Z, Li Z, Xu C, Li J, Hu C, Li Q, Xu X, Liu X, Liu Z, Xu L, Chen Y, Luo H, Wei L, Zhang X, Xin J, Guo J, Wang Q, Yuan Z, Zhou L, Zhang K, Zhang W, Yang J, Zhong X, Xia S, Li L, Cheng J, Ma E, He P, Lee SS, Wang Y, Uyeki TM, Yang W: Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 2008, 3(8):e2985.
• [5]Chen H, Smith GJ, Zhang SY, Qin K, Wang J, Li KS, Webster RG, Peiris JS, Guan Y: Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005, 436(7048):191-2.
• [6]Komar N, Olsen B: Avian influenza virus (H5N1) mortality surveillance. Emerg Infect Dis 2008, 14(7):1176-8.
• [7]China CDC[http://www.chinacdc.cn/n272562/n275973/33855.html] webcite 2009.
• [8]Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N: Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279(5349):393-6.
• [9]World Health Organization: [http:/ / www.who.int/ csr/ disease/ avian_influenza/ country/ cases_table_2009_12_30/ en/ index.html] webciteCumulative number of confirmed human cases of avian influenza A/(H5N1) reported to who. 2009.
• [10]Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S: Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005, 352(4):333-40.
• [11]Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH: Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006, 368(9554):2211-8.
• [12]Sambhara S, Poland GA: H5N1 avian influenza: preventive and therapeutic strategies against pandemic. Annu rev med 2010, 61:187-98.
• [13]Dwyer DE, Smith DW, Catton MG, Barr IG: Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006, 185(10 Suppl):S48-53.
• [14]Fronhoffs S, Totzke G, Stier S, Wernert N, Rothe M, Brüning T, Koch B, Sachinidis A, Vetter H, Ko Y: A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes 2002, 16(2):99-110.
• [15]World health organization: [http://www.who.int/csr/disease/avian_influenza/guidelines/avian_labtests2.pdf] webciteRecommended laboratory tests to identify avian influenza A virus in specimens from humans.
• [16]Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20:37-46.
• [17]Altman DG: Practical statistics for medical research. London: Chapman and Hall/CRC; 1990.
• [18]Meijer A, Brown C, Hungnes O, Schweiger B, Valette M, van der Werf S, Zambon M: Virology Task Groups of the European Influenza Surveillance Scheme: Programme of the Community Network of Reference Laboratories for Human Influenza to Improve Influenza Surveillance in Europe. Vaccine 2006, 24(44-46):6717-23.
• [19]Libeer JC: Role of external quality assurance schemes in assessing and improving quality in medical laboratories. Clin Chim Acta 2001, 309:173-7.
• [20]Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE: Quality control in molecular genetic testing. Nat Rev Genet 2001, 2:717-23.
• [21]Hertzberg M, Neville S, Favaloro E, McDonald D: External quality assurance of DNA testing for thrombophilia mutations. Am J Clin Pathol 2005, 123(2):189-93.
• [22]Hertzberg M, Neville S, McDonald D: External quality assurance of molecular analysis of haemochromatosis gene mutations. J Clin Pathol 2006, 59(7):744-7.
• [23]Ramsden SC, Deans Z, Robinson DO, Mountford R, Sistermans EA, Grody WW, McQuaid S, Patton SJ, Stenhouse SA: Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland. Genet Test 2006, 10(3):147-56.
• [24]Losekoot M, Bakker B, Laccone F, Stenhouse S, Elles R: A European pilot quality assessment scheme for molecular diagnosis of Huntington's disease. Eur J Med Genet 1999, 7:217-22.
• [25]Mueller CR, Kristoffersson U, Stoppa-Lyonnet D: External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years. Ann Oncol 2004, 15(Suppl 1):I14-I17.